Argun Akcakanat

4PUBLICATIONS
31CO-AUTHORS
Molecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 29, 2025
Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations.

Kaushik Varadarajan, Christian X Cruz Pico, Kurt W Evans

|Nov 25, 2024
Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models.

Funda Meric-Bernstam, Erkan Yuca, Kurt W Evans

|Feb 15, 2024
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts.

Timothy P DiPeri, Kurt W Evans, Bailiang Wang

|Oct 10, 2017
Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer.

S-U Woo, T Sangai, A Akcakanat

Pageof 1

Frequent Collaborators

3 joint publications

Kurt W Evans

3 joint publications

Bailiang Wang

3 joint publications

Ming Zhao

3 joint publications

Maria Gabriela Raso